#Experimental condition mappings as of Feb 25, 2022
#WITH_INFO	WITH_INFO term	conditionClassId	ZECO term	conditionStatement
CHEBI:46631	clonidine	ZECO:0000111	chemical treatment	chemical treatment:clonidine
CHEBI:50845	doxycycline	ZECO:0000111	chemical treatment	chemical treatment:doxycycline
XCO:0000005	running on treadmill	ZECO:0000131	stress
XCO:0000010	air oxygen content	ZECO:0000131	stress
XCO:0000013	diet	ZECO:0000112	diet
XCO:0000014	controlled content diet	ZECO:0000112	diet
XCO:0000015	controlled calorie content diet	ZECO:0000112	diet
XCO:0000017	nephrectomy	ZECO:0000229	physical alteration
XCO:0000018	bilateral nephrectomy	ZECO:0000229	physical alteration	physical alteration:bilateral nephrectomy
XCO:0000022	controlled sodium content diet	ZECO:0000112	diet	diet:controlled sodium content diet
XCO:0000025	controlled fat content diet	ZECO:0000112	diet
XCO:0000030	controlled protein content diet	ZECO:0000112	diet
XCO:0000032	controlled potassium content diet	ZECO:0000239	chemical treatment by diet
XCO:0000048	auditory stimulus	ZECO:0000131	stress	stress:auditory stimulus
XCO:0000055	tactile electric shock exposure	ZECO:0000131	stress
XCO:0000056	naive control condition	ZECO:0000101	control conditions
XCO:0000069	standard diet	ZECO:0000101	control conditions
XCO:0000090	"7,12-dimethyltetraphene (DMBA)"	ZECO:0000111	chemical treatment	"chemical treatment:7,12-dimethyltetraphene (DMBA)"
XCO:0000092	17 beta-estradiol	ZECO:0000111	chemical treatment	chemical treatment:17 beta-estradiol
XCO:0000094	ovariectomy	ZECO:0000229	physical alteration	physical alteration:ovariectomy
XCO:0000100	sham surgical control condition	ZECO:0000101	control conditions
XCO:0000102	fasting	ZECO:0000113	food availability
XCO:0000103	glucose solution	ZECO:0000111	chemical treatment
XCO:0000112	unilateral nephrectomy	ZECO:0000229	physical alteration	physical alteration:unilateral nephrectomy
XCO:0000113	right nephrectomy	ZECO:0000229	physical alteration	physical alteration:right nephrectomy
XCO:0000114	left nephrectomy	ZECO:0000229	physical alteration
XCO:0000121	NG-nitroarginine methyl ester	ZECO:0000111	chemical treatment
XCO:0000135	receptor agonist	ZECO:0000111	chemical treatment
XCO:0000143	acetylcholine	ZECO:0000111	chemical treatment
XCO:0000145	phenylephrine	ZECO:0000111	chemical treatment
XCO:0000154	ion/salt solution	ZECO:0000111	chemical treatment
XCO:0000155	sodium chloride solution	ZECO:0000111	chemical treatment
XCO:0000157	physical restraint	ZECO:0000131	stress	stress:physical restraint
XCO:0000158	physical restraint in mechanical restrainer	ZECO:0000131	stress
XCO:0000159	physical restraint in tube type rodent restrainer	ZECO:0000131	stress
XCO:0000160	receptor antagonist	ZECO:0000111	chemical treatment
XCO:0000163	controlled content drinking water	ZECO:0000112	diet
XCO:0000164	controlled sodium content drinking water	ZECO:0000112	diet	diet:controlled sodium content drinking water
XCO:0000165	surgical manipulation	ZECO:0000229	physical alteration
XCO:0000168	controlled in situ renal perfusion pressure	ZECO:0000229	physical alteration
XCO:0000177	thrombin	ZECO:0000111	chemical treatment
XCO:0000178	thapsigargin	ZECO:0000111	chemical treatment
XCO:0000181	controlled visible light condition	ZECO:0000146	lighting conditions
XCO:0000184	calcium ion	ZECO:0000111	chemical treatment
XCO:0000185	calcium ion solution	ZECO:0000111	chemical treatment
XCO:0000191	angiotensin II	ZECO:0000111	chemical treatment
XCO:0000192	deoxycorticosterone acetate	ZECO:0000111	chemical treatment
XCO:0000193	peptide/protein	ZECO:0000111	chemical treatment
XCO:0000195	myelin oligodendrocyte glycoprotein	ZECO:0000105	biological treatment	biological treatment:myelin oligodendrocyte glycoprotein
XCO:0000201	orchiectomy	ZECO:0000229	physical alteration
XCO:0000203	bilateral orchiectomy	ZECO:0000229	physical alteration
XCO:0000206	N-nitrosodiethylamine	ZECO:0000111	chemical treatment	chemical treatment:N-nitrosodiethylamine
XCO:0000207	3-methyl-4'-dimethylaminoazobenzene	ZECO:0000111	chemical treatment
XCO:0000210	partial hepatectomy	ZECO:0000229	physical alteration
XCO:0000211	controlled sucrose content diet	ZECO:0000239	chemical treatment by diet
XCO:0000212	controlled copper content diet	ZECO:0000112	diet	diet:controlled copper content diet
XCO:0000228	peptide hormone	ZECO:0000111	chemical treatment
XCO:0000231	anti-RT6.1 antibody	ZECO:0000111	chemical treatment
XCO:0000235	Poly I:C	ZECO:0000111	chemical treatment	chemical treatment:Poly I:C
XCO:0000237	viral pathogen	ZECO:0000105	biological treatment
XCO:0000238	Kilham rat virus	ZECO:0000105	biological treatment	biological treatment:Kilham rat virus
XCO:0000240	toxin	ZECO:0000111	chemical treatment
XCO:0000241	streptozotocin	ZECO:0000111	chemical treatment	chemical treatment:streptozotocin
XCO:0000244	controlled fructose content diet	ZECO:0000112	diet	diet:controlled fructose content diet
XCO:0000245	insulin	ZECO:0000111	chemical treatment
XCO:0000246	controlled cholesterol content diet	ZECO:0000112	diet
XCO:0000252	tolbutamide	ZECO:0000111	chemical treatment
XCO:0000255	anti-glomerular basement membrane antibody	ZECO:0000105	biological treatment	biological treatment:anti-glomerular basement membrane antibody
XCO:0000256	isoproterenol	ZECO:0000111	chemical treatment
XCO:0000262	collagen	ZECO:0000111	chemical treatment
XCO:0000263	pristane	ZECO:0000111	chemical treatment	chemical treatment:pristane
XCO:0000264	Freund's adjuvant	ZECO:0000111	chemical treatment
XCO:0000265	Freund's incomplete adjuvant	ZECO:0000111	chemical treatment	chemical treatment:Freund's incomplete adjuvant
XCO:0000266	Freund's complete adjuvant	ZECO:0000111	chemical treatment	chemical treatment:Freund's complete adjuvant
XCO:0000268	balloon angioplasty	ZECO:0000229	physical alteration
XCO:0000270	captopril	ZECO:0000111	chemical treatment	chemical treatment:captopril
XCO:0000273	carrageenan	ZECO:0000111	chemical treatment
XCO:0000275	glucose	ZECO:0000111	chemical treatment	chemical treatment:glucose
XCO:0000280	squalene	ZECO:0000111	chemical treatment	chemical treatment:squalene
XCO:0000281	type II collagen	ZECO:0000105	biological treatment	biological treatment:type II collagen
XCO:0000282	anti-Thy1 antibody	ZECO:0000105	biological treatment	biological treatment:anti-Thy1 antibody
XCO:0000283	visible light stimulus	ZECO:0000146	lighting conditions
XCO:0000285	controlled NG-nitroarginine methyl ester content drinking water	ZECO:0000239	chemical treatment by diet
XCO:0000288	R16 peptide of interphotoreceptor retinoid-binding protein	ZECO:0000105	biological treatment	biological treatment:R16 peptide of interphotoreceptor retinoid-binding protein
XCO:0000291	peripheral myelin protein 2 peptide 58-81	ZECO:0000105	biological treatment	biological treatment:peripheral myelin protein 2 peptide 58-81
XCO:0000292	peripheral nerve myelin	ZECO:0000105	biological treatment	biological treatment:peripheral nerve myelin
XCO:0000295	diethylstilbestrol	ZECO:0000111	chemical treatment	chemical treatment:diethylstilbestrol
XCO:0000296	running on inclined treadmill	ZECO:0000131	stress
XCO:0000297	fluid deprivation	ZECO:0000112	diet
XCO:0000298	controlled saccharin content drinking water	ZECO:0000239	chemical treatment by diet
XCO:0000304	bilateral adrenalectomy	ZECO:0000229	physical alteration
XCO:0000306	cold exposure	ZECO:0000160	temperature exposure
XCO:0000307	cold ambient air exposure	ZECO:0000160	temperature exposure
XCO:0000308	heat exposure	ZECO:0000160	temperature exposure
XCO:0000310	guanethidine	ZECO:0000111	chemical treatment
XCO:0000312	potassium chloride solution	ZECO:0000111	chemical treatment
XCO:0000317	buffered calcium ion solution	ZECO:0000111	chemical treatment
XCO:0000325	ethanol	ZECO:0000111	chemical treatment	chemical treatment:ethanol
XCO:0000329	controlled deoxycorticosterone content saline drink	ZECO:0000239	chemical treatment by diet
XCO:0000337	air-jet exposure	ZECO:0000131	stress	stress:air-jet exposure
XCO:0000341	chemical with specified function	ZECO:0000111	chemical treatment
XCO:0000345	N-ethyl-N-nitrosourea	ZECO:0000111	chemical treatment
XCO:0000348	middle cerebral artery occlusion	ZECO:0000229	physical alteration	physical alteration:middle cerebral artery occlusion
XCO:0000351	4-nitroquinoline N-oxide	ZECO:0000111	chemical treatment	chemical treatment:4-nitroquinoline N-oxide
XCO:0000356	spinal cord homogenate	ZECO:0000105	biological treatment	biological treatment:spinal cord homogenate
XCO:0000367	sham surgical device implantation	ZECO:0000101	control conditions
XCO:0000369	aurothiopropanol sulfonate	ZECO:0000111	chemical treatment	chemical treatment:aurothiopropanol sulfonate
XCO:0000372	dexamethasone	ZECO:0000111	chemical treatment
XCO:0000373	surgical denervation	ZECO:0000229	physical alteration
XCO:0000382	controlled captopril content drinking water	ZECO:0000112	diet	diet:controlled captopril content drinking water
XCO:0000392	nucleoside/nucleotide	ZECO:0000111	chemical treatment
XCO:0000393	"1,2-dimethylhydrazine"	ZECO:0000111	chemical treatment	"chemical treatment:1,2-dimethylhydrazine"
XCO:0000397	bisphenol A	ZECO:0000111	chemical treatment
XCO:0000432	sucrose	ZECO:0000111	chemical treatment
XCO:0000437	controlled N-propyl-N-nitrosourea content drinking water	ZECO:0000112	diet	diet:controlled N-propyl-N-nitrosourea content drinking water
XCO:0000438	candesartan	ZECO:0000111	chemical treatment
XCO:0000442	controlled 2-acetamidofluorene content diet	ZECO:0000239	chemical treatment by diet
XCO:0000444	controlled dexamethasone content drinking water	ZECO:0000239	chemical treatment by diet
XCO:0000451	Herpes simplex virus type 1	ZECO:0000105	biological treatment	biological treatment:Herpes simplex virus type 1
XCO:0000452	controlled casein content diet	ZECO:0000112	diet
XCO:0000464	controlled ex vivo organ condition	ZECO:0000229	physical alteration
XCO:0000466	controlled ex vivo artery perfusion pressure	ZECO:0000229	physical alteration
XCO:0000468	vitamin A	ZECO:0000111	chemical treatment
XCO:0000469	isotretinoin	ZECO:0000111	chemical treatment	chemical treatment:isotretinoin
XCO:0000483	antibacterial agent	ZECO:0000111	chemical treatment
XCO:0000498	oxidopamine	ZECO:0000111	chemical treatment
XCO:0000520	neuromodulation	ZECO:0000223	electric field
XCO:0000521	direct electrical nerve stimulation	ZECO:0000223	electric field
XCO:0000522	common peroneal nerve direct electrical stimulation	ZECO:0000223	electric field
XCO:0000529	gene transfer using adenovirus vector	ZECO:0000105	biological treatment
XCO:0000535	lisinopril	ZECO:0000111	chemical treatment
XCO:0000537	olmesartan medoxomil	ZECO:0000111	chemical treatment	chemical treatment:olmesartan medoxomil
XCO:0000539	doxorubicin	ZECO:0000111	chemical treatment
XCO:0000542	enalapril	ZECO:0000111	chemical treatment
XCO:0000545	vitamin D3	ZECO:0000111	chemical treatment
XCO:0000547	paricalcitol	ZECO:0000111	chemical treatment
XCO:0000548	ramipril	ZECO:0000111	chemical treatment
XCO:0000551	hydralazine	ZECO:0000111	chemical treatment
XCO:0000555	controlled lisinopril content drinking water	ZECO:0000239	chemical treatment by diet
XCO:0000561	antidepressant	ZECO:0000111	chemical treatment
XCO:0000587	intracerebroventricular cannula implantation	ZECO:0000229	physical alteration
XCO:0000588	Perindopril	ZECO:0000111	chemical treatment	chemical treatment:Perindopril
XCO:0000591	quinapril	ZECO:0000111	chemical treatment
XCO:0000592	cilazapril	ZECO:0000111	chemical treatment
XCO:0000599	aldosterone	ZECO:0000111	chemical treatment
XCO:0000600	"2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)"	ZECO:0000111	chemical treatment
XCO:0000602	rosiglitazone	ZECO:0000111	chemical treatment	chemical treatment:rosiglitazone
XCO:0000610	morphine	ZECO:0000111	chemical treatment
XCO:0000612	Endothelin-1	ZECO:0000111	chemical treatment
XCO:0000613	Adenosine triphosphate	ZECO:0000111	chemical treatment
XCO:0000630	cholinergic antagonist	ZECO:0000111	chemical treatment
XCO:0000637	cyclosporine A	ZECO:0000111	chemical treatment
XCO:0000638	Capsazepine	ZECO:0000111	chemical treatment
XCO:0000641	Myocardial reperfusion	ZECO:0000229	physical alteration
XCO:0000642	monocrotaline	ZECO:0000111	chemical treatment
XCO:0000644	anti-T cell receptor antibody	ZECO:0000111	chemical treatment
XCO:0000645	propofol	ZECO:0000111	chemical treatment	chemical treatment:propofol
XCO:0000646	Azoxymethane	ZECO:0000111	chemical treatment	chemical treatment:Azoxymethane
XCO:0000649	trans-4-hydroxy-L-proline	ZECO:0000111	chemical treatment	chemical treatment:trans-4-hydroxy-L-proline
XCO:0000655	prion	ZECO:0000105	biological treatment	biological treatment:prion
XCO:0000658	nisoldipine	ZECO:0000111	chemical treatment	chemical treatment:nisoldipine
XCO:0000662	"two-kidney, one-clip occlusion"	ZECO:0000229	physical alteration
XCO:0000667	clenbuterol	ZECO:0000111	chemical treatment
XCO:0000668	arterial catheter implantation and controlled hemorrhage	ZECO:0000229	physical alteration
XCO:0000669	diazoxide	ZECO:0000111	chemical treatment
XCO:0000670	Pair-fed diet	ZECO:0000112	diet
XCO:0000675	gene transfer using retrovirus vector	ZECO:0000105	biological treatment
XCO:0000677	controlled enalapril content drinking water	ZECO:0000239	chemical treatment by diet
XCO:0000679	fenofibrate	ZECO:0000111	chemical treatment
XCO:0000681	Medica 16	ZECO:0000111	chemical treatment
XCO:0000682	Benfluorex	ZECO:0000111	chemical treatment
XCO:0000683	cholestyramine	ZECO:0000111	chemical treatment
XCO:0000688	myelin basic protein	ZECO:0000105	biological treatment	biological treatment:myelin basic protein
XCO:0000691	controlled vitamin C content diet	ZECO:0000239	chemical treatment by diet
XCO:0000703	"2,4,5 trimethylthiazoline"	ZECO:0000111	chemical treatment
XCO:0000704	carotid artery occlusion	ZECO:0000229	physical alteration	physical alteration:carotid artery occlusion
XCO:0000709	cancer cells	ZECO:0000105	biological treatment
XCO:0000727	splenectomy	ZECO:0000229	physical alteration
XCO:0000731	controlled enrasentan content diet	ZECO:0000112	diet	diet:controlled enrasentan content diet
XCO:0000734	chemerin-9	ZECO:0000111	chemical treatment
XCO:0000735	paclitaxel	ZECO:0000111	chemical treatment
XCO:0000736	diphtheria toxin	ZECO:0000105	biological treatment	biological treatment:diphtheria toxin
XCO:0000769	antiserum	ZECO:0000105	biological treatment	biological treatment:antiserum
XCO:0000779	rat IgM immunocytoma cells	ZECO:0000105	biological treatment
XCO:0000790	controlled sodium chloride content drinking water	ZECO:0000239	chemical treatment by diet
XCO:0000795	controlled sodium chloride content diet	ZECO:0000112	diet	diet:controlled sodium chloride content diet
XCO:0000798	nociceptin	ZECO:0000111	chemical treatment
XCO:0000801	controlled gliadin content diet	ZECO:0000112	diet
XCO:0000818	gene transfer using plasmid vector	ZECO:0000105	biological treatment
XCO:0000833	lacidipine	ZECO:0000111	chemical treatment
XCO:0000834	formaldehyde	ZECO:0000111	chemical treatment
XCO:0000843	mecamylamine	ZECO:0000111	chemical treatment
XCO:0000844	sodium phenobarbital	ZECO:0000111	chemical treatment
XCO:0000845	pregnenolone 16alpha-carbonitrile	ZECO:0000111	chemical treatment
XCO:0000861	control IgG monoclonal antibody	ZECO:0000111	chemical treatment
XCO:0000879	triamcinolone acetonide	ZECO:0000111	chemical treatment
XCO:0000880	mifepristone	ZECO:0000111	chemical treatment
XCO:0000887	pentetrazol	ZECO:0000111	chemical treatment
XCO:0000888	pilocarpine	ZECO:0000111	chemical treatment
XCO:0000889	ionomycin	ZECO:0000111	chemical treatment
XCO:0000891	phorbol 13-acetate 12-myristate	ZECO:0000111	chemical treatment
XCO:0000897	capsaicin	ZECO:0000111	chemical treatment
XCO:0000898	minoxidil	ZECO:0000111	chemical treatment
XCO:0000906	ovalbumin	ZECO:0000111	chemical treatment
XCO:0000907	liraglutide	ZECO:0000111	chemical treatment
XCO:0000913	ethosuximide	ZECO:0000111	chemical treatment
XCO:0000914	cafeteria diet	ZECO:0000112	diet
XCO:0000922	semaxanib	ZECO:0000111	chemical treatment